Skip navigation

 Login or Register | Member Centre

GlobeInvestorGOLD Canada's most comprehensive investment tool.

 
Change Symbol: Lookup Trade Now

Astrazeneca PLC | Headlines

  • Vol:
  • Last Trade:
Search found 65 documents NextNext
1: US FDA Approves New Indication for CRESTOR(R) (rosuvastatin calcium)
PR NEWSWIRE, February 8, 2010 07:09 PM

2: Atlantis™ Patient-Specific Abutment Now Available for NobelActive™ Implants
Business Wire, February 3, 2010 07:00 AM

3: AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
PR NEWSWIRE, January 18, 2010 10:00 AM

4: AstraZeneca Offers Online Enrollment and Additional Improvements to Patient Assistance Program
PR NEWSWIRE, January 13, 2010 10:45 AM

5: AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA(TM)), an Investigational Antiplatelet Agent
PR NEWSWIRE, November 19, 2009 02:00 AM

6: Results From Two Phase II Trials Add to Understanding of Ticagrelor (BRILINTA(TM)) and How it Works in the Body
PR NEWSWIRE, November 18, 2009 09:15 AM

7: Video: CRESTOR(R) Reduced Risk of Cardiovascular Events in Women by Nearly Half in New Analysis of JUPITER Study
PR NEWSWIRE, November 17, 2009 04:00 PM

8: MedImmune Announces Winners of the 4th Respiratory, Immunology and Autoimmunity Research Abstract Competition
PR NEWSWIRE, November 16, 2009 05:45 PM

9: Video: Ticagrelor (BRILINTA(TM)) Demonstrated Greater Efficacy Over Clopidogrel in the Most Urgent Clinical Setting: Patients with ST-Segment Elevation Myocardial Infarction and Planned Percutaneous Coronary Intervention (PCI)
PR NEWSWIRE, November 15, 2009 08:00 AM

10: Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps
PR NEWSWIRE, November 11, 2009 02:41 PM

NextNext
 

Search using one or more of the following options:

Symbol Lookup
 
 
  Search Tips
 
  * Can only be used when searching The Globe and Mail and newswires.

Back to top